Annual EBITDA
$23.07M$99.43M+130.21%
Summary
- Current Value
- As of today, EXAS annual EBITDA is $23.07M, up +130.21% on
- Historical Performance
- EXAS annual EBITDA is up +104.41% over the past 3 years, and up +120.01% over the past 5 years
- All-Time High Comparison
- EXAS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- EXAS annual EBITDA is +105.84% above its 3-year low of -$394.72M reached on an earlier date
- Sector Comparison
- EXAS annual EBITDA is higher than 81.07% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $23.07M | +130.2% | +104.4% | +120.0% | +378.8% | |
| Quarterly EBITDA | $72.17M | +181.3% | +204.5% | +34.5% | +2264.5% | |
| TTM EBITDA | $97.60M | +544.6% | +121.5% | +313.2% | +1115.0% | |
| Price | $102.11 | +80.2% | +73.6% | -22.1% | +1585.0% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $2.76B | +10.4% | +56.1% | +214.8% | +10000.0% | |
| Annual EPS | -$5.59 | -392.9% | -60.7% | -772.9% | -1894.9% | |
| Annual EBIT | -$191.79M | +38.3% | +73.7% | -12.2% | -2195.5% | |
| Annual Net Income | -$1.03B | -404.0% | -72.7% | -1124.9% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $23.07M | at high | |
| 5Y | $23.07M | at high | |
| All | $23.07M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$394.72M | N/A | +105.8% |
| 5Y | -$523.04M | +104.4% | |
| All | -$523.04M | +104.4% |
EBITDA History
FAQ
What is the current annual EBITDA of EXAS?
As of today, EXAS annual EBITDA is $23.07M
What is 1-year change in EXAS annual EBITDA?
EXAS annual EBITDA is up +130.21% year-over-year
What is 3-year change in EXAS annual EBITDA?
EXAS annual EBITDA is up +104.41% over the past 3 years
How far is EXAS annual EBITDA from its all-time high?
EXAS annual EBITDA is currently at its all-time high
How does EXAS annual EBITDA rank versus sector peers?
EXAS annual EBITDA is higher than 81.07% of companies in Healthcare sector
When is EXAS next annual earnings release?
The next annual earnings release for EXAS is on
Quarterly EBITDA
$72.17M$14.12M+24.33%
Summary
- Current Value
- As of today, EXAS quarterly EBITDA is $72.17M, up +24.33% on
- Historical Performance
- EXAS quarterly EBITDA is up +181.28% year-over-year, and up +204.54% over the past 3 years
- All-Time High Comparison
- EXAS quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- EXAS quarterly EBITDA is +218.73% above its 3-year low of -$60.78M reached on an earlier date
- Sector Comparison
- EXAS quarterly EBITDA is higher than 87.16% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $72.17M | +24.3% | +181.3% | +204.5% | +34.5% | |
| Annual EBITDA | $23.07M | – | +130.2% | +104.4% | +120.0% | |
| TTM EBITDA | $97.60M | +91.0% | +544.6% | +121.5% | +313.2% | |
| Price | $102.11 | +71.7% | +80.2% | +73.6% | -22.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $850.74M | +4.9% | +20.1% | +62.6% | +108.3% | |
| Quarterly EPS | -$0.10 | -1542.9% | +50.0% | +87.7% | +92.3% | |
| Quarterly EBIT | $16.28M | +489.5% | +155.9% | +113.0% | +157.2% | |
| Quarterly Net Income | -$19.59M | -1553.5% | +48.8% | +86.8% | +90.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $72.17M | at high | |
| 3Y | $72.17M | at high | |
| 5Y | $72.17M | at high | |
| All | $72.17M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$43.99M | +264.1% | |
| 3Y | -$60.78M | N/A | +218.7% |
| 5Y | -$240.80M | +130.0% | |
| All | -$240.80M | +130.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of EXAS?
As of today, EXAS quarterly EBITDA is $72.17M
What is EXAS quarterly EBITDA most recent change?
EXAS quarterly EBITDA was up +24.33% on September 30, 2025
What is 1-year change in EXAS quarterly EBITDA?
EXAS quarterly EBITDA is up +181.28% year-over-year
How far is EXAS quarterly EBITDA from its all-time high?
EXAS quarterly EBITDA is currently at its all-time high
How does EXAS quarterly EBITDA rank versus sector peers?
EXAS quarterly EBITDA is higher than 87.16% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on
TTM EBITDA
$97.60M$46.51M+91.04%
Summary
- Current Value
- As of today, EXAS TTM EBITDA is $97.60M, up +91.04% on
- Historical Performance
- EXAS TTM EBITDA is up +544.62% year-over-year, and up +121.47% over the past 3 years
- All-Time High Comparison
- EXAS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- EXAS TTM EBITDA is +128.32% above its 3-year low of -$344.58M reached on an earlier date
- Sector Comparison
- EXAS TTM EBITDA is higher than 83.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $97.60M | +91.0% | +544.6% | +121.5% | +313.2% | |
| Annual EBITDA | $23.07M | – | +130.2% | +104.4% | +120.0% | |
| Quarterly EBITDA | $72.17M | +24.3% | +181.3% | +204.5% | +34.5% | |
| Price | $102.11 | +71.7% | +80.2% | +73.6% | -22.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $3.08B | +4.8% | +14.5% | +53.7% | +133.4% | |
| TTM EPS | -$5.32 | +1.9% | -353.7% | -29.7% | -145.2% | |
| TTM EBIT | -$120.78M | +27.3% | +49.2% | +82.2% | +42.3% | |
| TTM Net Income | -$986.58M | +1.9% | -360.9% | -37.7% | -201.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $97.60M | at high | |
| 3Y | $97.60M | at high | |
| 5Y | $97.60M | at high | |
| All | $97.60M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $14.48M | N/A | +573.8% |
| 3Y | -$344.58M | N/A | +128.3% |
| 5Y | -$569.60M | +117.1% | |
| All | -$569.60M | +117.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of EXAS?
As of today, EXAS TTM EBITDA is $97.60M
What is EXAS TTM EBITDA most recent change?
EXAS TTM EBITDA was up +91.04% on September 30, 2025
What is 1-year change in EXAS TTM EBITDA?
EXAS TTM EBITDA is up +544.62% year-over-year
How far is EXAS TTM EBITDA from its all-time high?
EXAS TTM EBITDA is currently at its all-time high
How does EXAS TTM EBITDA rank versus sector peers?
EXAS TTM EBITDA is higher than 83.73% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- EXAS Official Website www.exactsciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1124140/000112414025000091/0001124140-25-000091-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124140/000112414025000020/0001124140-25-000020-index.htm
- EXAS Profile on Yahoo Finance finance.yahoo.com/quote/EXAS
- EXAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exas